Replies to post #14663 on Hemispherx BioPharma (HEB)

[JohnnyD3]

I think it depends on when they sell. They've got plenty of cash now. Within 6 months they'll have an expanded ampligen treatment program for CFS here and abroad - it's difficult to tell what form that will take however. By mid year, if all goes well, they should have alferon approval. It's off to the races then - they won't be able to make enough alferon, even if they add another reactor or two.